Literature DB >> 22858445

Acute effects of prostaglandin E1 and E2 on vascular reactivity and blood flow in situ in the chick chorioallantoic membrane.

D R Harland1, L D Lorenz1, K Fay1, B E Dunn2,3, S K Gruenloh1, J Narayanan4, E R Jacobs1,3, M Medhora4.   

Abstract

The chick chorioallantoic membrane (CAM) subserves gas exchange in the developing embryo and shell-less culture affords a unique opportunity for direct observations over time of individual blood vessels to pharmacologic interventions. We tested a number of lipids including prostaglandins PGE(1&2) for vascular effects and signaling in the CAM. Application of PGE(1&2) induced a decrease in the diameter of large blood vessels and a concentration-dependent, localized, reversible loss of blood flow through small vessels. The loss of flow was also mimicked by misoprostol, an agonist for 3 of 4 known PGE receptors, EP(2-4), and by U46619, a thromboxane mimetic. Selective receptor antagonists for EP(3) and thromboxane each partially blocked the response. This is a first report of the effects of prostaglandins on vasoreactivity in the CAM. Our model allows the unique ability to examine simultaneous responses of large and small vessels in real time and in vivo.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858445      PMCID: PMC3839254          DOI: 10.1016/j.plefa.2012.07.002

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  52 in total

1.  Thromboxane and the thromboxane receptor in cardiovascular disease.

Authors:  Emer M Smyth
Journal:  Clin Lipidol       Date:  2010-04-01

Review 2.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

Authors:  R A Coleman; W L Smith; S Narumiya
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

3.  EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.

Authors:  Vikram Jadhav; Anthony Jabre; Shinn-Zong Lin; Tony Jer-Fu Lee
Journal:  J Cereb Blood Flow Metab       Date:  2004-12       Impact factor: 6.200

Review 4.  Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).

Authors:  Randall E Harris; Joanne Beebe-Donk; Hani Doss; Deborah Burr Doss
Journal:  Oncol Rep       Date:  2005-04       Impact factor: 3.906

Review 5.  Prostanoids in health and disease.

Authors:  Emer M Smyth; Tilo Grosser; Miao Wang; Ying Yu; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2008-12-17       Impact factor: 5.922

6.  Blood plasma influences anti-aggregatory potency of prostaglandins: effect of albumin.

Authors:  G Kobzar; V Mardla; I Järving; N Samel
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

7.  Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay.

Authors:  Maria Grazia Cattaneo; Sandra Pola; Valeria Dehò; Anna Maria Sanguini; Lucia Maria Vicentini
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.

Authors:  J Senior; K Marshall; R Sangha; J K Clayton
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

Review 9.  Molecular mechanisms of diverse actions of prostanoid receptors.

Authors:  M Negishi; Y Sugimoto; A Ichikawa
Journal:  Biochim Biophys Acta       Date:  1995-10-26

10.  Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth.

Authors:  Hideki Amano; Izumi Hayashi; Hirahito Endo; Hidero Kitasato; Shohei Yamashina; Takayuki Maruyama; Michiyoshi Kobayashi; Kazutoyo Satoh; Masami Narita; Yukihiko Sugimoto; Takahiko Murata; Hirokuni Yoshimura; Shuh Narumiya; Masataka Majima
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.